Intravenous Solutions Market Analysis Report By Type, By Nutrients, By Region And Segment Forecasts From 2021 To 2028

Synopsis

The global intravenous solutions market was prized by USD 10.7 billion in 2020. It is estimated to witness a 7.9% CAGR from 2021 to 2028.

Drivers

The frequency of undernourishment, particularly among the aged residents, because of chronic sicknesses like cancer, is projected to increase the demand for intravenous (IV) solutions during the near future.

One of the frequent side effects of cancer is dehydration. The effects similar to extreme urination, vomiting, or diarrhea, are sourced by chemotherapy. It generates dehydration and which increases the necessity for hydration, via intravenous solutions.

In addition, the demand for IV solutions is likely to boost illnesses like diarrhea, which causes a reduction of liquid from the body. Every year, more than a billion cases of babyhood diarrheal sickness are accounted for. But, merely in serious cases, the option of intravenous solutions is chosen, otherwise, Oral Rehydration Therapy (ORS) is chosen.

Furthermore, several untimely babies get nourishment via IV solutions. There has been a constant rise in the rate of preterm births, in the U.S. preterm birth affects 1 of each 10 babies born within the nation. These intravenous solutions are customized for every child. The fluid holds electrolytes, calories, and proteins. Therefore, by way of the rise in the figure of untimely births, demand for intravenous solutions is estimated to augment.

Effect of Covid-19

The demand for intravenous solutions has augmented due to the eruption of the Covid-19 pandemic. Globally, the Intensive Care Units (ICU) are flooding by the Covid-19 patients. The multiple waves coming of Covid-19 strains are causing the growing number of admissions in the hospitals in various nations, globally. Numerous patients, particularly senior-aged people are kept on ventilators. In these situations, nourishment is given via intravenous solutions.

Furthermore, the World Health Organization (WHO) has suggested that the patients who had a respiratory failure due to the Covid-19 must be taken care of using intravenous fluids, particularly in the background of mechanical ventilation. Therefore, mostly for the duration of the pandemic, the demand for intravenous solutions is projected to impale.

Type Insight

The Total Parenteral Nutrition (TPN) sector held the major, roughly 65.8% revenue share and led the intravenous solutions market, in 2020. It is anticipated to carry on its domination, during the forecast period. Based on the type of nutrition, the market is subdivided into Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN).

The TPN segment is, furthermore, anticipated to develop fast due to its augmented significance in the curing of constant inflammatory bowel sickness for example ulcerative colitis and Crohn's disease. In the U.S., this upsets every year, approximately 1.6 million persons. Total Parenteral Nutrition (TPN) assists to retain sufficient nourishment within the body and adjust undernourishment in patients by way of dysfunctional digestive systems.

Nutrients Insight

The single-dose amino acid solution division held the biggest, more than 31.4% revenue share and led the intravenous (IV) solutions market, in 2020. It is expected to carry on its supremacy, during the forecast period. On the source of nutrients, the market is subdivided into parenteral lipid emulsion, single dose amino acid solution, vitamins & minerals (salt and electrolyte), and carbohydrates.

The increasing occurrences of hepatic diseases, kidney failure, and protein deficiency diseases (Marasmus and kwashiorkor), are encouraging the greater utilization of amino acid injections. Besides, augmented endorsements of better amino acids, by way of a smaller amount of undesirable results, are furthermore powering enlargement of the intravenous solutions market.

The vitamins & minerals (salts and electrolytes) section is estimated to observe the maximum 9.7% CAGR, during the forecast period. The input factors adding to its higher growth comprise the rising figure of the surgical treatments and dietetic administration after the operation; curing of the sicknesses, similar to continual mental circumstances, beriberi, pellagra, anemia, along with the replacement treatment.

Regional Insight

In 2020, North America held the major, 40.8% revenue share and led the global intravenous solutions market. Mainly, the U.S.A. is a significant market and forms the highest share of revenue, within the region. The nation is supported by the top player, Baxter. It provides approximately 50.0% quantity of the IV solutions, within the hospitals within the nation. On the other hand, the nation yet confronts the scarcity of intravenous solutions, owing to the influenza period, stressing the necessity for intravenous solutions, within the nation.

The Asia Pacific is expected to be the highest rising area for the duration of the forecast. India is one of the highly growing nations, where 24.0% of the global size, premature births take place. This stands for each year the sum of 3.5 million premature births. Such untimely born babies are at a greater threat of inadequate development and grasping the infection.

Therefore, before time parenteral nutrition is essential for preterm babies and has to provide sufficient energy and amino acids. Therefore, India is likely to be a crucial revenue producer of the market for intravenous solutions shortly.

Companies

The major companies offer an extensive variety of products, by way of diverse compositions precise to various sickness circumstances. The policy of joint venture is likely to help in joining the difference between the supply and demand for intravenous solutions.

Some of the companies for the intravenous solutions market are:

    • Baxter
    • B. Braun Melsungen AG
    • Hospira
    • Fresenius Kabi
    • Terumo Corporation

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For this study, Million Insights has segmented the global intravenous solutions market based on type, nutrients, and region:

• Type Outlook (Revenue, USD Million, 2016 - 2028)
    • Total Parenteral Nutrition (TPN)
    • Peripheral Parenteral Nutrition (PPN)

• Nutrients Outlook (Revenue, USD Million, 2016 - 2028)
    • Carbohydrates
    • Single Dose Amino Acid Solution
    • Vitamins & Minerals (Salt and electrolyte)
    • Parenteral Lipid Emulsion
    • Others

• Regional Outlook (Revenue, USD Million, 2016 - 2028)
    • North America
        • U.S.
        • Canada
    • Europe
        • U.K.
        • Germany
        • France
        • Russia
        • Switzerland
    • The Asia Pacific
        • Japan
        • China
        • India
        • Australia
        • South Korea
    • Latin America
        • Brazil
        • Mexico
    • Middle East & Africa
        • South Africa